Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;11(2):899-911.
doi: 10.1007/s40123-022-00459-1. Epub 2022 Jan 31.

Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Uveitis

Affiliations

Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Uveitis

Francesca Della Casa et al. Ophthalmol Ther. 2022 Apr.

Abstract

Introduction: The aim of this paper is to point out the design, development and deployment of the AutoInflammatory Disease Alliance (AIDA) International Registry for paediatric and adult patients with non-infectious uveitis (NIU).

Methods: This is a physician-driven, population- and electronic-based registry implemented for both retrospective and prospective collection of real-world demographics, clinical, laboratory, instrumental and socioeconomic data of patients with uveitis and other non-infectious inflammatory ocular diseases recruited through the AIDA Network. Data recruitment, based on the Research Electronic Data Capture (REDCap) tool, is thought to collect standardised information for real-life research and has been developed to change over time according to future scientific acquisitions and potentially communicate with other similar instruments. Security, data quality and data governance are cornerstones of this platform.

Results: Ninety-five centres have been involved from 19 countries and four continents from 24 March to 16 November 2021. Forty-eight out of 95 have already obtained the approval from their local ethics committees. At present, the platform counts 259 users (95 principal investigators, 160 site investigators, 2 lead investigators, and 2 data managers). The AIDA Registry collects baseline and follow-up data using 3943 fields organised into 13 instruments, including patient's demographics, history, symptoms, trigger/risk factors, therapies and healthcare utilization for patients with NIU.

Conclusions: The development of the AIDA Registry for patients with NIU will facilitate the collection of standardised data leading to real-world evidence and enabling international multicentre collaborative research through inclusion of patients and their families worldwide.

Keywords: Autoinflammatory diseases; Clinical management; Innovative biotechnologies; International registry; Personalised medicine; Precision medicine; Rare diseases; Uveitis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Countries involved in the AIDA Network based on the number of centres for each country

References

    1. Fabiani C, Vitale A, Orlando I, et al. Impact of uveitis on quality of life: a prospective study from a tertiary referral rheumatology—Ophthalmology Collaborative Uveitis Center in Italy. Isr Med Assoc J. 2017;19(8):478–483. - PubMed
    1. Rothova A, Buitenhuis HJ, Meenken C, et al. Uveitis and systemic disease. Br J Ophthalmol. 1992;76(3):137–141. doi: 10.1136/bjo.76.3.137. - DOI - PMC - PubMed
    1. Tsirouki T, Dastiridou A, Symeonidis C, et al. A focus on the epidemiology of uveitis. Ocul Immunol Inflamm. 2018;26(1):2–16. doi: 10.1080/09273948.2016.1196713. - DOI - PubMed
    1. Joltikov KA, Lobo-Chan AM. Epidemiology and risk factors in non-infectious uveitis: a systematic review. Front Med (Lausanne) 2021;10(8):695904. doi: 10.3389/fmed.2021.695904. - DOI - PMC - PubMed
    1. de Parisot A, Kodjikian L, Errera MH, et al. Randomized controlled trial evaluating a standardized strategy for uveitis etiologic diagnosis (ULISSE) Am J Ophthalmol. 2017;178:176–185. doi: 10.1016/j.ajo.2017.03.029. - DOI - PubMed

LinkOut - more resources